As on Thursday, GoodRx Holdings Inc (NASDAQ: GDRX) got off with the flyer as it spiked 3.54% to $6.73, before settling in for the price of $6.50 at the close. Taking a more long-term approach, GDRX posted a 52-week range of $4.14-$9.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 26.70% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.14%. This publicly-traded company’s shares outstanding now amounts to $92.36 million, simultaneously with a float of $76.75 million. The organization now has a market capitalization sitting at $2.66 billion. At the time of writing, stock’s 50-day Moving Average stood at $6.87, while the 200-day Moving Average is $6.34.
GoodRx Holdings Inc (GDRX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Health Information Services industry. GoodRx Holdings Inc’s current insider ownership accounts for 80.57%, in contrast to 13.28% institutional ownership. According to the most recent insider trade that took place on Nov 30 ’23, this organization’s insider bought 21,652 shares at the rate of 5.76, making the entire transaction reach 124,806 in total value, affecting insider ownership by 182,900. Preceding that transaction, on Nov 29 ’23, Company’s insider bought 26,348 for 5.90, making the whole transaction’s value amount to 155,482. This particular insider is now the holder of 161,248 in total.
GoodRx Holdings Inc (GDRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 6.73 per share during the current fiscal year.
GoodRx Holdings Inc’s EPS increase for this current 12-month fiscal period is 31.14% and is forecasted to reach 0.42 in the upcoming year.
GoodRx Holdings Inc (NASDAQ: GDRX) Trading Performance Indicators
Let’s observe the current performance indicators for GoodRx Holdings Inc (GDRX). It’s Quick Ratio in the last reported quarter now stands at 7.12. The Stock has managed to achieve an average true range (ATR) of 0.34. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.54. Similarly, its price to free cash flow for trailing twelve months is now 19.37.
In the same vein, GDRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.02, a figure that is expected to reach 0.07 in the next quarter, and analysts are predicting that it will be 0.42 at the market close of one year from today.
Technical Analysis of GoodRx Holdings Inc (GDRX)
Through scrutinizing the latest numbers posted by the [GoodRx Holdings Inc, GDRX], it can be observed that its last 5-days Average volume of 0.93 million was lower the volume of 1.56 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 21.23% While, its Average True Range was 0.32.
Raw Stochastic average of GoodRx Holdings Inc (GDRX) in the period of the previous 100 days is set at 44.92%, which indicates a major rise in contrast to 38.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 36.91% that was lower than 63.42% volatility it exhibited in the past 100-days period.
